Avaí Bio, Inc. (AVAI)

OTCMKTS · Delayed Price · Currency is USD
0.360
0.00 (0.00%)
Mar 6, 2026, 3:30 PM EST
42.86%
Market Cap 49.77M
Revenue (ttm) n/a
Net Income (ttm) -1.03M
Shares Out 138.25M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,500
Average Volume 77,084
Open 0.360
Previous Close 0.360
Day's Range 0.360 - 0.360
52-Week Range 0.219 - 0.828
Beta 1.06
RSI 34.89
Earnings Date Feb 10, 2026

About Avaí Bio

Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. Further, it offers Avant! AI, a platform that has shown impressive results related to the technology’s usage, access, and performance; and InstantFAME. The company was formerly known as Avant Technologies Inc. and changed its name to Avaí Bio, Inc. in Fe... [Read more]

Sector Technology
Founded 2017
Country United States
Stock Exchange OTCMKTS
Ticker Symbol AVAI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.